200 related articles for article (PubMed ID: 21955333)
1. 4-nitrobenzyloxycarbonyl derivatives of O(6)-benzylguanine as hypoxia-activated prodrug inhibitors of O(6)-alkylguanine-DNA alkyltransferase (AGT), which produces resistance to agents targeting the O-6 position of DNA guanine.
Zhu R; Liu MC; Luo MZ; Penketh PG; Baumann RP; Shyam K; Sartorelli AC
J Med Chem; 2011 Nov; 54(21):7720-8. PubMed ID: 21955333
[TBL] [Abstract][Full Text] [Related]
2. Design of a hypoxia-activated prodrug inhibitor of O6-alkylguanine-DNA alkyltransferase.
Zhu R; Seow HA; Baumann RP; Ishiguro K; Penketh PG; Shyam K; Sartorelli AC
Bioorg Med Chem Lett; 2012 Oct; 22(19):6242-7. PubMed ID: 22932317
[TBL] [Abstract][Full Text] [Related]
3. KS900: A hypoxia-directed, reductively activated methylating antitumor prodrug that selectively ablates O(6)-alkylguanine-DNA alkyltransferase in neoplastic cells.
Baumann RP; Ishiguro K; Penketh PG; Shyam K; Zhu R; Sartorelli AC
Biochem Pharmacol; 2011 May; 81(10):1201-10. PubMed ID: 21396917
[TBL] [Abstract][Full Text] [Related]
4. A strategy for selective O(6)-alkylguanine-DNA alkyltransferase depletion under hypoxic conditions.
Penketh PG; Shyam K; Baumann RP; Ishiguro K; Patridge EV; Zhu R; Sartorelli AC
Chem Biol Drug Des; 2012 Aug; 80(2):279-90. PubMed ID: 22553921
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-selective O6-alkylguanine-DNA alkyltransferase inhibitors: design, synthesis, and evaluation of 6-(benzyloxy)-2-(aryldiazenyl)-9H-purines as prodrugs of O6-benzylguanine.
Zhu R; Baumann RP; Penketh PG; Shyam K; Sartorelli AC
J Med Chem; 2013 Feb; 56(3):1355-9. PubMed ID: 23311288
[TBL] [Abstract][Full Text] [Related]
6. Reductive activation of the prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119) selectively occurs in oxygen-deficient cells and overcomes O(6)-alkylguanine-DNA alkyltransferase mediated KS119 tumor cell resistance.
Baumann RP; Penketh PG; Ishiguro K; Shyam K; Zhu YL; Sartorelli AC
Biochem Pharmacol; 2010 Jun; 79(11):1553-61. PubMed ID: 20005211
[TBL] [Abstract][Full Text] [Related]
7. The antineoplastic efficacy of the prodrug Cloretazine is produced by the synergistic interaction of carbamoylating and alkylating products of its activation.
Baumann RP; Seow HA; Shyam K; Penketh PG; Sartorelli AC
Oncol Res; 2005; 15(6):313-25. PubMed ID: 16408696
[TBL] [Abstract][Full Text] [Related]
8. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): I. Direct inhibition of O6-alkylguanine-DNA alkyltransferase (AGT) by electrophilic species generated by decomposition.
Penketh PG; Shyam K; Baumann RP; Remack JS; Brent TP; Sartorelli AC
Cancer Chemother Pharmacol; 2004 Apr; 53(4):279-87. PubMed ID: 14704831
[TBL] [Abstract][Full Text] [Related]
9. Resistance-modifying agents. 8. Inhibition of O(6)-alkylguanine-DNA alkyltransferase by O(6)-alkenyl-, O(6)-cycloalkenyl-, and O(6)-(2-oxoalkyl)guanines and potentiation of temozolomide cytotoxicity in vitro by O(6)-(1-cyclopentenylmethyl)guanine.
Griffin RJ; Arris CE; Bleasdale C; Boyle FT; Calvert AH; Curtin NJ; Dalby C; Kanugula S; Lembicz NK; Newell DR; Pegg AE; Golding BT
J Med Chem; 2000 Nov; 43(22):4071-83. PubMed ID: 11063604
[TBL] [Abstract][Full Text] [Related]
10. NBGNU: a hypoxia-activated tripartite combi-nitrosourea prodrug overcoming AGT-mediated chemoresistance.
Ge Y; Lai X; Li J; Yu R; Zhuang Z; Sun G; Cui X; Zhang N; Zhao L; Upadhyaya P; Zhong R
Future Med Chem; 2019 Feb; 11(4):269-284. PubMed ID: 30560688
[No Abstract] [Full Text] [Related]
11. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of O6-alkylguanine-DNA alkyltransferase in cytotoxicity.
Baumann RP; Shyam K; Penketh PG; Remack JS; Brent TP; Sartorelli AC
Cancer Chemother Pharmacol; 2004 Apr; 53(4):288-95. PubMed ID: 14685775
[TBL] [Abstract][Full Text] [Related]
12. Role of O6-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine.
Ishiguro K; Shyam K; Penketh PG; Sartorelli AC
Mol Cancer Ther; 2005 Nov; 4(11):1755-63. PubMed ID: 16275997
[TBL] [Abstract][Full Text] [Related]
13. Protection of CHO cells by mutant forms of O6-alkylguanine-DNA alkyltransferase from killing by 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) plus O6-benzylguanine or O6-benzyl-8-oxoguanine.
Loktionova NA; Xu-Welliver M; Crone TM; Kanugula S; Pegg AE
Biochem Pharmacol; 1999 Jul; 58(2):237-44. PubMed ID: 10423163
[TBL] [Abstract][Full Text] [Related]
14. Reductive Activity and Mechanism of Hypoxia- Targeted AGT Inhibitors: An Experimental and Theoretical Investigation.
Xiao W; Sun G; Fan T; Liu J; Zhang N; Zhao L; Zhong R
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847200
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor activity evaluation of a novel combi-nitrosourea prodrug: Designed to release a DNA cross-linking agent and an inhibitor of O(6)-alkylguanine-DNA alkyltransferase.
Sun G; Zhang N; Zhao L; Fan T; Zhang S; Zhong R
Bioorg Med Chem; 2016 May; 24(9):2097-107. PubMed ID: 27041398
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-induced O(6)-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancer.
Liu L; Schwartz S; Davis BM; Gerson SL
Cancer Res; 2002 Jun; 62(11):3070-6. PubMed ID: 12036916
[TBL] [Abstract][Full Text] [Related]
17. Development and biological evaluation of AzoBGNU: A novel hypoxia-activated DNA crosslinking prodrug with AGT-inhibitory activity.
Liu Q; Wang X; Li J; Wang J; Sun G; Zhang N; Ren T; Zhao L; Zhong R
Biomed Pharmacother; 2021 Dec; 144():112338. PubMed ID: 34678728
[TBL] [Abstract][Full Text] [Related]
18. O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.
Spiro TP; Gerson SL; Liu L; Majka S; Haaga J; Hoppel CL; Ingalls ST; Pluda JM; Willson JK
Cancer Res; 1999 May; 59(10):2402-10. PubMed ID: 10344750
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of O(6)-alkylguanine-DNA alkyltransferase by folate esters of O(6)-benzyl-2'-deoxyguanosine and of O(6)-[4-(hydroxymethyl)benzyl]guanine.
Javanmard S; Loktionova NA; Fang Q; Pauly GT; Pegg AE; Moschel RC
J Med Chem; 2007 Oct; 50(21):5193-201. PubMed ID: 17880193
[TBL] [Abstract][Full Text] [Related]
20. Chloroethylating and methylating dual function antineoplastic agents display superior cytotoxicity against repair proficient tumor cells.
Zhu R; Baumann RP; Patridge E; Penketh PG; Shyam K; Ishiguro K; Sartorelli AC
Bioorg Med Chem Lett; 2013 Mar; 23(6):1853-9. PubMed ID: 23395657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
